Cargando…

Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells

BACKGROUND: Nasopharyngeal carcinoma (NPC) has a high relapse and metastatic rates; hence, development of new therapeutics is an immediate requirement. Lapatinib and everolimus have been demonstrated to be effective in the treatment of several carcinomas. This preclinical study aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lin, Wang, Zhi-Hui, Han, Jun, Tang, Con, Chen, Nan, Lin, Zhong, Peng, Pei-Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067011/ https://www.ncbi.nlm.nih.gov/pubmed/27785067 http://dx.doi.org/10.2147/OTT.S115309

Ejemplares similares

Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways
por: Liu, Lin, et al.
Publicado: (2016)

Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Pyr Dit Ruys, Sébastien, et al.
Publicado: (2012)

Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Ruys, S. Pyr Dit, et al.
Publicado: (2012)

Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase
por: Ballard, Darby J., et al.
Publicado: (2021)

Lapatinib-Binding Protein Kinases in the African Trypanosome: Identification of Cellular Targets for Kinase-Directed Chemical Scaffolds
por: Katiyar, Samiksha, et al.
Publicado: (2013)

Control of eukaryotic transcription elongation
por: Winston, Fred
Publicado: (2001)

Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer
por: Ng, Tung H., et al.
Publicado: (2019)

Correction: Lapatinib-Binding Protein Kinases in the African Trypanosome: Identification of Cellular Targets for Kinase-Directed Chemical Scaffolds
Publicado: (2014)

Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer
por: Wang, Xuemin, et al.
Publicado: (2017)

Structural basis for the calmodulin-mediated activation of eukaryotic elongation factor 2 kinase
por: Piserchio, Andrea, et al.
Publicado: (2022)

ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin
por: Piserchio, Andrea, et al.
Publicado: (2023)

Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells
por: Sanges, C, et al.
Publicado: (2012)

Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells
por: Sanges, C, et al.
Publicado: (2012)

Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis
por: Liu, Li-na, et al.
Publicado: (2013)

Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains
por: Pigott, Craig R., et al.
Publicado: (2012)

Eukaryotic elongation factor 2 kinase regulates the synthesis of microtubule‐related proteins in neurons
por: Kenney, Justin W., et al.
Publicado: (2015)

Impairing Eukaryotic Elongation Factor 2 Kinase Activity Decreases Atherosclerotic Plaque Formation
por: Zhang, Peng, et al.
Publicado: (2014)

A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors
por: Xiao, Ting, et al.
Publicado: (2016)

Activated estrogen receptor-mitogen-activated protein kinases cross talk confer acquired resistance to lapatinib
por: Li, Zhe, et al.
Publicado: (2015)

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma
por: Peng, Pei-Jian, et al.
Publicado: (2015)

Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells
por: OKITA, RIKI, et al.
Publicado: (2015)

Inhibition of Eukaryotic Translation Elongation by Cycloheximide and Lactimidomycin
por: Schneider-Poetsch, Tilman, et al.
Publicado: (2010)

Eukaryotic Elongation Factor 2 Kinase Activity Is Required for the Phenotypes of the Rpl24(Bst) Mouse
por: Knight, John R.P., et al.
Publicado: (2022)

Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation
por: Aimjongjun, Sathid, et al.
Publicado: (2019)

Cellular Effects of Everolimus and Sirolimus on Podocytes
por: Müller-Krebs, Sandra, et al.
Publicado: (2013)

Anticancer Effect of Fucoidan in Combination with Tyrosine Kinase Inhibitor Lapatinib
por: Oh, Byeongsang, et al.
Publicado: (2014)

Control of CD4(+) T cells to restrain inflammatory diseases via eukaryotic elongation factor 2 kinase
por: Peng, Hao-Yun, et al.
Publicado: (2023)

An evolutionary ratchet leading to loss of elongation factors in eukaryotes
por: Atkinson, Gemma C, et al.
Publicado: (2014)

Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib
por: Kancha, Rama Krishna, et al.
Publicado: (2011)

Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC
por: Pott, Leona L, et al.
Publicado: (2017)

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines
por: Dratkiewicz, Ewelina, et al.
Publicado: (2018)

Stm1p alters the ribosome association of eukaryotic elongation factor 3 and affects translation elongation
por: Van Dyke, Natalya, et al.
Publicado: (2009)

Age-dependent increase in activity of eukaryotic elongation factor 2 kinase in mesenteric arteries from spontaneously hypertensive rats
por: KODAMA, Tomoko, et al.
Publicado: (2020)

Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter
por: Radic-Sarikas, Branka, et al.
Publicado: (2017)

Distinct RPA functions promote eukaryotic DNA replication initiation and elongation
por: Pike, Alexandra M, et al.
Publicado: (2023)

Eukaryotic elongation factor 2 kinase inhibitor, A484954 inhibits noradrenaline-induced acute increase of blood pressure in rats
por: KODAMA, Tomoko, et al.
Publicado: (2018)

Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor
por: Piserchio, Andrea, et al.
Publicado: (2023)

The Eukaryotic Elongation Factor 1A Is Critical for Genome Replication of the Paramyxovirus Respiratory Syncytial Virus
por: Wei, Ting, et al.
Publicado: (2014)

The Nrf2 inhibitor brusatol synergistically enhances the cytotoxic effect of lapatinib in HER2-positive cancers
por: Tian, Ziyin, et al.
Publicado: (2022)

Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma
por: Song, Yang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2qcr3mkk38agsjqj7jl7aaj0p8